SCHEMBL23968657

SCHEMBL23968657

CC(C)(C)OC(=O)NC[C@H]1CC[C@H](C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)O)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.68
▸ KMT2A Q03164 2/20 0.68
▸ MEN1 O00255 1/20 0.66
▸ ACACB O00763 4/20 0.55
▸ CTSB P07858 1/20 0.55
▸ CTSS P25774 1/20 0.55
▸ CTSK P43235 1/20 0.55
▸ MAPK1 P28482 1/20 0.51
▸ PTPN1 P18031 1/20 0.50
▸ FOLH1 Q04609 3/20 0.49
▸ PLG P00747 1/20 0.49
▸ PRSS1 P07477 1/20 0.49
▸ PRSS2 P07478 1/20 0.49
▸ PRSS3 P35030 1/20 0.49
▸ ACACA Q13085 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ MME P08473 1/20 0.47
▸ ACE P12821 1/20 0.47
▸ CPA1 P15085 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388983 0.90 KMT2A (0.82) ATMKMT2AMEN1ACACBCTSB
SCHEMBL388984 0.90 KMT2A (0.82) ATMKMT2AMEN1ACACBCTSB
SCHEMBL28057007 0.90 KMT2A (0.82) ATMKMT2AMEN1ACACBCTSB
Dimethylamine SCHEMBL10425391 0.88 KMT2A (0.79) ATMKMT2AMEN1ACACBCTSB
SCHEMBL25964562 0.86 KMT2A (0.70) ATMKMT2AMEN1ACACBMAPK1
SCHEMBL16604417 0.86 KMT2A (0.70) ATMKMT2AMEN1ACACBMAPK1
SCHEMBL16606603 0.85 KMT2A (0.63) ATMKMT2AMEN1ACACBMAPK1
SCHEMBL30309096 0.85 KMT2A (0.68) ATMKMT2AMEN1ACACBMAPK1
SCHEMBL18011186 0.85 KMT2A (0.68) ATMKMT2AMEN1ACACBCTSB
SCHEMBL16606805 0.85 KMT2A (0.68) ATMKMT2AMEN1ACACBCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11160886-B2 Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds BRACCO IMAGING SPA (IT) 2021-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11160886-B2 Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds PNP, TK1, NT5E ATM 2664/4885KMT2A 4465/4885MEN1 999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback